Transcatheter implantation of the Tendyne mitral valve replacement device for treatment of mitral regurgitation in patients at prohibitive surgical risk because of severe mitral annular calcification ...
Abbott said Tuesday it received Food and Drug Administration approval for the Tendyne transcatheter mitral valve replacement system to treat calcium buildup in the ring that supports the heart valve.
ABBOTT PARK, Ill., Jan. 30, 2020 /PRNewswire/ -- Abbott (NYSE: ABT) today announced that its Tendyne™ Transcatheter Mitral Valve Implantation (TMVI) system received CE Mark and is now approved for use ...
Abbott’s MitraClip implant just got a new sibling. The FDA has approved the company’s Tendyne system, as a minimally invasive heart replacement for patients with mitral valve disease that would ...
Please provide your email address to receive an email when new articles are posted on . A transcatheter mitral valve replacement system was approved for patients at high surgical risk. The system is ...
The Tendyne system replaces mitral valves that are not functioning properly due to a buildup of calcium in the base of the valves, known as severe mitral annular calcification (MAC) Tendyne offers a ...
ROSEVILLE, Minn., Tendyne Holdings, Inc. ("Tendyne"), a privately held clinical stage medical device company, announced today that the Tendyne Transcatheter Mitral Valve system has been successfully ...
Boise, Idaho-based Saint Alphonsus Regional Medical Center became the first in the state to perform a Tendyne mitral valve replacement, the Daily Fly reported Dec. 7. The device is inserted through a ...
Two-year outcomes following transcatheter mitral valve replacement with the Tendyne prosthesis showed durable control of mitral regurgitation, sustained improvement in quality of life and functional ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results